TB Is Still Rife Fifty Years After The Study Which Found A Cure

Tuberculosis: story or medical failure?

In a week when the world of medicine is celebrating the 50th anniversary of the first randomised controlled trial, Chris Holme, journalist at the Herald newspaper in Glasgow, laments the irony that half a century on, the disease that this trial found the means to eradicate, is still rife.

The MRC trial, which was published in the BMJ on 30 October 1948, found Streptomycin to be an effective treatment of tuberculosis. In a stinging attack in this week's BMJ, the author writes that despite the results of this trial there has been a failure to implement treatment regimens, which has led to an international resurgence of the disease.

The author details the path of complacency that he believes has led to the epidemic we are now witnessing in the 1990s and asks: "why after an estimated one million controlled trials on every treatment under the sun, have we failed to apply the results of the initial ones on tuberculosis chemotherapy?"


Chris Holme, Herald, Glasgow, Scotland

(Contact through Jill Shepherd at BMJ press office Wednesday 28 - Friday 30 October)


Contact: Jill Shepherd
BMJ-British Medical Journal

Page: 1

Related biology news :

1. Still waters? Clear-cutting robs the deep-sea of ancient treasures
2. Salmon Syndrome M74: Cause Still A Mystery
3. Fetal Surgery For Spina Bifida Still Under Investigation At VUMC
4. Rapid Population Growth Is Still A Problem
5. Creatine Works, But Long-Term Effects Are Still Unknown
6. HIV Patients Often Experience Viral "Breakthrough," But May Still Remain Healthy, San Francisco Study Finds
7. Reduced Nutrients Still Cause Problems In The Neuse And Tar-Pamlico Rivers
8. Fifty years later, famous photo is in OSUs Pauling collection
9. Years of research, thought lead geologist to propose new supercontinent Columbia
10. Fossilized Emu Eggshells Give Clues To 65,000 Years Of Vegetation And Climate Changes In Australia
11. Earliest Modern Tree Lived 360-345 Million Years Ago

Post Your Comments:

(Date:3/4/2020)... ... March 04, 2020 , ... Vitamin Science, Inc, a manufacturer ... multi-dimensional nutraceutical formula for ocular blue light protection. , VisiVite Blue Light ... the retina’s healthy pigmentation and improve the eye’s management of high energy blue ...
(Date:3/3/2020)... (PRWEB) , ... March 03, 2020 , ... Amplify Surgical, ... with the dualX Expanding Interbody Fusion System. , The landmark case was ... After the case Dr. Najafi noted, “dualX has completely changed the game for ...
(Date:3/2/2020)... (PRWEB) , ... March 02, 2020 , ... Nominations are ... program co-founded by the Security Industry Association (SIA) and SecureIDNews ... SIA Women in Security Forum . The recipients of this year’s Women in Biometrics ...
Breaking Biology News(10 mins):
(Date:2/21/2020)... ... February 21, 2020 , ... Join Forrest Brown, Engineering Services Manager ... Sequence, Inc. for an informative session on Wednesday, February 26, 2020 ... elements to incorporate into facility design to add manufacturing flexibility in the future, especially ...
(Date:2/19/2020)... , ... February 18, 2020 , ... ... devices, today announced the launch of a new and unified global brand identity, ... the industry’s most complex engineering challenges, as well as an enthusiasm for designing ...
(Date:2/11/2020)... ... February 11, 2020 , ... INSPAN ... a long-term follow-up clinical study of outpatient L4-L5 lumbar interspinous fixation for ... extension block design, the Inspan device fixates the spine to allow for ...
(Date:2/5/2020)... , ... February 04, 2020 , ... ... for characterizing microbiome populations down to the strain level, has announced a new ... Shoreline Biome’s microbiome kits and other products to companies and research organizations in ...
Breaking Biology Technology:
Cached News: